We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy (LAPAINBLAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01245660
Recruitment Status : Terminated (The rythm of enrollment was not compatible with the objective of recruitement in the research.)
First Posted : November 22, 2010
Last Update Posted : January 11, 2013
Information provided by (Responsible Party):
University Hospital, Bordeaux

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2011
  Study Completion Date : October 2011